Brian Holly, M.D., an interventional radiologist with the Johns Hopkins Interventional Radiology Center, specializes in treating uterine fibroids through a treatment called uterine fibroid embolization (UFE).
Uterine artery embolization (often referred to as “uterine fibroid embolization” or “UFE”) is an innovative outpatient procedure most commonly used to treat symptomatic fibroids.
Uterine fibroid embolization (UFE) is a minimally invasive treatment for tumors (growths of tissue) on the wall of your uterus. Fibroids, also called myomas, are usually benign (not cancerous), but they can cause pain, heavy menstrual bleeding, and other symptoms that affect your quality of life.
Uterine fibroid embolization (UFE), also called uterine artery embolization (UAE), is a nonsurgical procedure performed by an interventional radiologist. First performed in the U.S. in 1997, UFE is widely used around the world.
Uterine fibroid embolization, or UFE, is a procedure that cuts off blood to a uterine fibroid. It does so by delivering a substance that creates a blood clot through a catheter inserted into a blood vessel.
Uterine fibroid embolization (UFE) (also known as UAE or Uterine Artery Embolization) shrinks uterine fibroids by depriving them of a blood supply using small particles called embolic agents.
To treat the uterine fibroids, an interventional radiologist (IR) can perform a treatment called uterine artery embolization (UAE), which is also referred to as uterine fibroid embolization (UFE). UFE avoids surgery, preserves your uterus, controls symptoms and significantly improves quality of life.
Uterine fibroid embolization (UFE) is used to shrink or destroy uterine fibroids. It is one type of treatment used in people who don't want to treat fibroids with a hysterectomy, don't plan to be pregnant in the future, and haven't reached menopause.